Frontiers in Aging Neuroscience (Jan 2021)

Mitochondria: Novel Mechanisms and Therapeutic Targets for Secondary Brain Injury After Intracerebral Hemorrhage

  • Weixiang Chen,
  • Weixiang Chen,
  • Weixiang Chen,
  • Weixiang Chen,
  • Chao Guo,
  • Chao Guo,
  • Chao Guo,
  • Chao Guo,
  • Hua Feng,
  • Hua Feng,
  • Hua Feng,
  • Hua Feng,
  • Yujie Chen,
  • Yujie Chen,
  • Yujie Chen,
  • Yujie Chen

DOI
https://doi.org/10.3389/fnagi.2020.615451
Journal volume & issue
Vol. 12

Abstract

Read online

Intracerebral hemorrhage (ICH) is a destructive form of stroke that often results in death or disability. However, the survivors usually experience sequelae of neurological impairments and psychiatric disorders, which affect their daily functionality and working capacity. The recent MISTIE III and STICH II trials have confirmed that early surgical clearance of hematomas does not improve the prognosis of survivors of ICH, so it is vital to find the intervention target of secondary brain injury (SBI) after ICH. Mitochondrial dysfunction, which may be induced by oxidative stress, neuroinflammation, and autophagy, among others, is considered to be a novel pathological mechanism of ICH. Moreover, mitochondria play an important role in promoting neuronal survival and improving neurological function after a hemorrhagic stroke. This review summarizes the mitochondrial mechanism involved in cell death, reactive oxygen species (ROS) production, inflammatory activation, blood–brain barrier (BBB) disruption, and brain edema underlying ICH. We emphasize the potential of mitochondrial protection as a potential therapeutic target for SBI after stroke and provide valuable insight into clinical strategies.

Keywords